TrialPath
Recruiting

The New Empowerment After eXposure to Trauma (NEXT) Study

NCT07175025 · Indiana University
In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

About this study
The NEXT Study is a randomized controlled pilot examining the feasibility and acceptability of a revised perinatal PTSD protocol. This study will randomize perinatal participants with PTSD to receive NET (n=45); treatment group) and will be compared to perinatal women randomized to usual care (n=45; comparator group). The overall objective of this project is to determine the most feasible and acceptable protocol for a brief virtual perinatal PTSD intervention.
Eligibility criteria
Inclusion Criteria: * 18 years of age or older * able to read and speak English * diagnosis of probable PTSD as determined by the PTSD Checklist for DSM-5 (PCL-5) * pregnant or postpartum (delivered within 12 weeks) at the time of the eligibility screen Exclusion criteria * current severe suicide risk as determined by the Columbia Suicide Severity Rating Scale Screener (C-SSRS) * current psychotic or manic symptoms as determined by the DIAMOND screener and the Mood Disorder Questionnaire for Bipolar Disorder * cognitive impairment * concurrent trauma-focused psychotherapy * medical advice limiting participation in exposure therapy * current legal actions related to trauma * does not meet criteria for PTSD * not pregnant or delivered more than 12 weeks after timing of eligibility screening
Study design
Enrollment target: 106 participants
Allocation: randomized
Masking: double
Age groups: adult
Timeline
Starts: 2025-09-24
Estimated completion: 2028-07-31
Last updated: 2026-06-18
Interventions
Behavioral: Narrative Exposure Therapy (NET)
Primary outcomes
  • • Feasibility Tracking (Baseline, post-intervention time period (12 weeks post-baseline), and follow-up (24 weeks post-baseline))
  • • Acceptability (Post-intervention time period (12 weeks post-baseline))
  • • Perinatal NET Protocol Acceptability Questionnaire (PNPAQ) (Post-intervention time period (12 weeks post-baseline) for the NET treatment group)
Sponsor
Indiana University · other
With: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Contacts & investigators
ContactMichelle L. Miller, PhD · contact · mlm41@iu.edu · 317-963-7257
ContactNeva Brown, BA · contact · mlm41@iu.edu
InvestigatorMichelle L. Miller, PhD · principal_investigator, Indiana University
All locations (1)
Indiana University School of MedicineRecruiting
Indianapolis, Indiana, United States